Clinical Trial Update: Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)

View source ↗

Summary

This clinical trial update shows a recruiting study evaluating biomarkers to predict progression from mild cognitive impairment to dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Snippet

Sponsor: Cuibai Wei，Clinical Professor | Conditions: Biomarkers, MCI Conversion to Dementia | Status: RECRUITING